Literature DB >> 20797477

Hypoxanthine levels in human urine serve as a screening indicator for the plasma total cholesterol and low-density lipoprotein modulation activities of fermented red pepper paste.

Yujin Kim1, Youn-Je Park, Seung-Ok Yang, So-Hyun Kim, Sun-Hee Hyun, Sayeon Cho, Young-Suk Kim, Dae Young Kwon, Youn-Soo Cha, Soowan Chae, Hyung-Kyoon Choi.   

Abstract

Fermented red pepper paste (FRPP) is one of the most well-known traditional foods in Korea. The effects of FRPP in experimental animals and adipocytes have been previously reported. However, the biochemical effects have not yet been validated in humans with various genetic backgrounds and environmental factors. In this study, 28 female volunteers (body mass index, more than 23 kg/m(2)) aged 19 to 60 years were treated with either FRPP or a placebo for 12 weeks. Marked cholesterol modulation was observed in the FRPP-treated group compared with the placebo group. Although the baseline (pretreatment) total cholesterol and low-density lipoprotein levels and body mass index of the volunteers did not differ significantly between the placebo- and FRPP-treated groups, FRPP caused a modulation of cholesterol levels not seen in the placebo group, causing either no variation or a decrease in low-density lipoprotein and total cholesterol levels. Thus, urinary metabolomic profiling of pretreatment samples was carried out in these 2 FRPP-treated groups using (1)H-nuclear magnetic resonance-based metabolomic techniques. These 2 groups, with their opposing cholesterol-modulation tendencies, could be clearly differentiated by orthogonal projections to latent structures-discriminant analysis-derived score plots. In addition, their levels of hypoxanthine differed markedly. We propose that urinary hypoxanthine levels can be used as a screening biomarker to predict the efficacy of the cholesterol-modulating activity of FRPP in human subjects. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797477     DOI: 10.1016/j.nutres.2010.06.014

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  6 in total

1.  Anti-hyperlipidemic effect of soybean extract fermented by Bacillus subtilis MORI in db/db mice.

Authors:  Yoonyi Nam; Harry Jung; Sankarapandian Karuppasamy; Jae-Yeon Lee; Kyung-Don Kang; Kyo-Yeol Hwang; Su-Il Seong; Jun-Gyo Suh
Journal:  Lab Anim Res       Date:  2012-06-26

Review 2.  A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome.

Authors:  Setareh Sanati; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

3.  Effects of Capsicum annuum supplementation on the components of metabolic syndrome: a systematic review and meta-analysis.

Authors:  Hwan-Hee Jang; Jounghee Lee; Sung-Hyen Lee; Young-Min Lee
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

4.  Lipid-Lowering Efficacy of the Capsaicin in Patients With Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zhonghui Jiang; Hua Qu; Gongyu Lin; Dazhuo Shi; Keji Chen; Zhuye Gao
Journal:  Front Nutr       Date:  2022-03-01

Review 5.  The Utility of Capsicum annuum L. in Internal Medicine and In Dentistry: A Comprehensive Review.

Authors:  Luciano Maria Catalfamo; Giulia Marrone; Michele Basilicata; Ilaria Vivarini; Vincenza Paolino; David Della-Morte; Francesco Saverio De Ponte; Francesca Di Daniele; Domenico Quattrone; Danilo De Rinaldis; Patrizio Bollero; Nicola Di Daniele; Annalisa Noce
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

6.  NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?

Authors:  Manuela Grimaldi; Angelica Palisi; Carmen Marino; Paola Montoro; Anna Capasso; Sara Novi; Mario Felice Tecce; Anna Maria D'Ursi
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.